Get started
Work

Safety and pharmacodynamics of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration.

Year: 2018
Type: conference-abstract
DOI: 10.1200/jco.2018.36.15_suppl.2595
Authors: Mark N. Stein, Jyoti Malhotra, Usha Malhotra, Ann W. Silk, Nancy Chan, Lorna Rodriguez-Rodriguez, Joseph Aisner, Robert Aiken, Jenna Newman, Evita Sadimin, Tracie Saunders, Melissa Frankel, Aparna Kareddula, Wafik S. El-Deiry, Rohinton Tarapore, Joshua E. Allen, Joseph R. Bertino, Steven K. Libutti, Janice M. Mehnert, Andrew Zloza
Institutions: Columbia University Irving Medical Center, Rutgers Cancer Institute, Rush University Medical Center, Fox Chase Cancer Center, Oncoceutics (United States), Albert Einstein College of Medicine
Language: English
Open Access status: closed
OpenAlex ID: W2891099435
Cites:
Cited by: 3
Related to: 10